Evotec repays 50% of € 140 m acquisition loan

 

  • STRONG OPERATIONAL CASHFLOW FACILITATES REPAYMENT OF € 70 M WITHIN THE FIRST YEAR OF THE LOAN TERM
  • € 140 M LOAN WAS TAKEN TO EXPAND EVOTEC’S VALUE CHAIN WITH APTUIT IN AUGUST 2017

 

Hamburg, Germany, 31 July 2018:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that it completes the repayment of 50% of the € 140 m debt bridge facility within the first year of being granted in context of the Aptuit acquisition in 2017. Effective August 2017, Evotec acquired Aptuit, a partner research organisation for integrated outsourced drug discovery and development, for € 253.2 m in cash. This acquisition was financed through existing cash reserves and a new € 140 m senior debt bridge facility.

The repayment of € 70 m within the first year of the loan period is enabled mainly through the strong cash inflow from Evotec’s operational activities in the first half of 2018. In addition, Evotec refinanced part of the loan at highly attractive terms. Evotec expects the repayment to show a significantly positive effect on the net debt ratio in the Company’s results.

Enno Spillner, Chief Financial Officer of Evotec, commented: “This early repayment underlines our strong cash-generating operating business, despite full commitments to our long-term EVT Innovate R&D and capacity-building strategy.”

FORWARD LOOKING STATEMENTS

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.